StockData
Biogen Inc. logo

Biogen Inc.

BIIBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3058% above fair value
$249.59+2.46 (+1.00%)

Close on Nov 20, 2026Market cap $36.89BP/E 106.7Yield –

Biogen Depreciation & Amortization by Quarter

Depreciation & Amortization ($M)

Biogen Depreciation & Amortization: $241M in Q3 2026, up 19.2% from a year earlier.

Latest, Q3 2026
241
Period ended Sep 30, 2026
Change on a year earlier
+19.2%
202 in Q3 2025
History
67 quarters
Since Q3 2008
Sources
49
Documents cited below

Where the Q3 2026 figure comes from

Calculated from reported figures: quarter = year-to-date − previous year-to-date (cash flow statement)

Source: Biogen Form 10-Q (filed 2026-10-28) ↗

Reported in SEC Form 10-Q / Form 10-K (GAAP Consolidated Financial Statements).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedDepreciation & Amortization ($M)Year on yearSource
Q3 2026Sep 30, 2026241+19.2%Biogen Form 10-Q (filed 2026-10-28) ↗
Q2 2026Jun 30, 2026236+21.5%Biogen Form 10-Q (filed 2026-07-29) ↗
Q1 2026Mar 31, 2026204+11.6%Biogen Form 10-Q (filed 2026-04-29) ↗
Q4 2025Dec 31, 2025200+8.8%Biogen Form 10-K (filed 2026-02-06) ↗
Q3 2025Sep 30, 2025202+10.6%Biogen Form 10-Q (filed 2025-10-30) ↗
Q2 2025Jun 30, 2025194+22.3%Biogen Form 10-Q (filed 2025-07-31) ↗
Q1 2025Mar 31, 2025183+24.2%Biogen Form 10-Q (filed 2025-05-01) ↗
Q4 2024Dec 31, 2024184+31.3%Biogen Form 10-K (filed 2025-02-12) ↗
Q3 2024Sep 30, 2024183+46.2%Biogen Form 10-Q (filed 2024-10-30) ↗
Q2 2024Jun 30, 2024159+35.3%Biogen Form 10-Q (filed 2024-08-01) ↗
Q1 2024Mar 31, 2024148+31.3%Biogen Form 10-Q (filed 2024-04-24) ↗
Q4 2023Dec 31, 2023140+16.9%Biogen Form 10-K (filed 2024-02-14) ↗
Q3 2023Sep 30, 2023125+3.6%Biogen Form 10-Q (filed 2023-11-08) ↗
Q2 2023Jun 30, 2023117-12.9%Biogen Form 10-Q (filed 2023-07-25) ↗
Q1 2023Mar 31, 2023112-21.5%Biogen Form 10-Q (filed 2023-04-25) ↗
Q4 2022Dec 31, 2022120-11.1%Biogen Form 10-K (filed 2023-02-15) ↗

Cite this data

StockData. (2026). Biogen Depreciation & Amortization ($M), quarterly Q3 2008–Q3 2026 [Data set]. Compiled from Biogen SEC filings and investor materials. https://stockdatahq.com/stocks/biib/kpis/db-da

See every metric in the Biogen KPI table. Data updated Nov 10, 2026.

See a number that looks wrong?